Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Zhejiang Jingxin Pharmaceutical Co Ltd (Jingxin Pharma) is a pharmaceutical company that carries out research and development, production, and sales of pharmaceutical products. The company's product offerings include drugs such as antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, antihyper cholesterolemia, histamine H2 receptor blockade, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and active pharmaceutical ingredients (APIs) such as levofloxacin hemihydrate, ciprofloxacin hydrochloride, ofloxacin, levofloxacin lactate, enrofloxacin base, ciprofloxacin lactate, enrofloxacin hydrochloride and rosuvastatin calcium, among others. Jingxin Pharma's products are used for the treatments in the fields of cardiovascular and cerebrovascular health, digestive tract issues, and psychological conditions. Jingxin Pharma is headquartered in Xinchang, Zhejiang, China.
Zhejiang Jingxin Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Drugs: |
| Antihypertensive |
| Antibiotics |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Zhejiang Jingxin Pharmaceutical Co Ltd | Humanwell Healthcare Group Co Ltd | Zhangzhou Pien Tze Huang Pharmaceutical Co Ltd | Shandong Xinhua Pharmaceutical Co Ltd | Yifan Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Shaoxing | Wuhan | Zhangzhou | Zibo | Hangzhou |
| State/Province | Zhejiang | Hubei | Fujian | Shandong | Zhejiang |
| No. of Employees | 3,869 | 17,650 | 2,839 | 7,159 | 4,098 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Lv Gang | Chairman; President | Executive Board | 2004 | 63 |
| Wang Nengneng | Vice Chairman | Executive Board | 2010 | 52 |
| Chen Meili | Chief Financial Officer; Director; Vice President | Executive Board | 2019 | 55 |
| Jin Zhiping | Director; President | Executive Board | 2019 | 44 |
| Hong Yunfei | Director; Secretary | Executive Board | 2019 | 45 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer